References
A. Azziz, ‘The evaluation and management of hirsutism.’ Obstetrics and Genecology 101, 2003, pp.995–1007.
E. Carmina and R.A. Lobo, ‘Polycystic ovary syndrome (PCOS): arguably the most common endocrinopathy is associated with significant morbidity in women.’ Journal of Clinical Endocrinology and Metabolism 84, 1999, pp.1897–1899.
A.M. Corbould, S.J. Judd and R.J. Rodgers, ‘Expression of types 1, 2,3 and 3 17 beta-hyroxesteroid dehydrogenase in subcutaneous abdominal and intra-abdominal adipose tissue of women.’ Journal of Clinical Endocrinology and Metabolism 83, 2001, pp.187-194.
E. Diamanti-Kandararakis, C. Houli, K. Alexandraki, G. Spina, ‘Failure of mathematical indices to accurately assess insulin resistance in lean, overweight, or obese women with polycystic ovary syndrome’ Journal of Clinical Endocrinology and Metabolism 89, 2004, pp.1273-1276.
A.Dunaif, ‘Insulin resistance and the polycystic ovarian syndrome: Mechanisms and implications for pathogenesis.’ Endocrine Reviews 18, 1997, pp.774–800.
E.S. Epel, E.H. Blackburn, J. Lin, F.S. Dhabhar, N.E. Alder, J.D. Morrow, R.M. Cawthorn, ‘Accelerated telomere shortening in response to life stress’ Proc. Natl. Acad. Sci.USA 101, 2004, pp.17312-17315.
A. Garg & A. Misra, ‘Hepatic steatosis, insulin resistance and adipose tissue disorders.’ Journal of Clinical Endocrinology and Metabolism 87, 2002, pp.3019–3022.
C.J. Glueck, N. Goldenberg, J. Pranikoff, M. Loftspring, L. Sieve, Wang P Height, ‘Weight and motor-social development during the first 18 months of life in 126 infants born to 109 mothers with polycystic ovary syndrome who conceived and continued through pregnancy’ Hum. Reprod 19, 2004, pp.1323-1330.
L. Ibanez, C. Valla, S. Cabre, F. De Zegher, ‘Flutamide-metformin plus ethinylestradiol-drospirenone for lipolysis and antiatherogenesis in young women with ovarian hyperandrogenism: the key role of early, low-dose flutamide’ Journal of Clinical Endocrinology and Metabolism 89, 2004, pp.4716-4720.
L Ibanez, C. Valls, N. Ptau, M.V. Marcus, F. de Zegher, ‘Polycystic ovary syndrome after precocious pubarche: ontogeny of low-birthweight effect.’ Clin. Endocrinol 55, 2001, pp.667-672.
D.J. Jakubowicz, P.A. Essah, M. Seppala, S. Jakubowics, J.P. Baillargeon, R Koistinen, J.F. Nestler ‘Reduced serum Glycodelin and Insulin-like Growth factor Protein-1 in Women with polycystic ovarian syndrome during the first trimester of pregnancy’ Journal of Clinical Endocrinology and Metabolism 89, 2004, pp.933-839.
D.J. Jakubowicz, M.J. Iuorno, S. Jakubowicz, K.A. Roberts and J.E. Nestler,‘Effects of metformin on early pregnancy loss in polycystic ovary syndrome.’ Journal of Clinical Endocrinology and Metabolism 87, 2001, pp.524–529.
R. Kaaja, H. Laivuori, M.Laasko, M.J.Tikkanen and O. Ylikorakala,‘Evidence of a state of increased insulin resistance in pre-eclampsia.’ Metabolism 48, 1999, pp.892–896.
J.M. Lord, I.H. Flight, R.J. Norman, ‘Metformin in polycystic ovary disease syndrome: systematic review and metanalysis’ BMJ 327, 2003, pp.951-953.
D. Kirpichnikov, S.I. McFarklane, J.R.Sowers, ‘Metformin: An update.’ Annals of Internal Medicine, 2002, pp.25-33.
U. Ozcan,Q. Cao, E. Yilmaz,A-H Lee,N.N. Iwakoshi, E. Ozleden, G. Tuncman, C. Gorgun, L.H. Glimcher, G.S. Hotamisligil, 'Endoplasmic reticulum stress links obesity, insulin action, and type 2 diabetes' Science 306, 2004, pp.457-461.
N.L. Ragon, R.C. Rao, S. Hwang, L.L. Alshuter, S. Elman, L. Zuckerbrow-Miller and S.G. Korenman, ‘Depression in women with polycystic ovarian disease: Clinical and biochemical correlates’ Journal of Affective Disorders 3, 2003, pp.299–304.
G.Taubes, ‘Insulin insults may spur Alzheimer’s disease.’ Science 301, 2003, pp.40–41.
M. Urbanek, R.S. Legro, D.A. Driscoll, R. Azziz, D.A. Ehrmann, R.J. Norman, J.F. Strauss 3rd,R.S.Spielman and A.Dunaif, ‘Thirty-seven candidate genes for polycystic ovary syndrome: Strongest evidence for linkage is with follistatin.’ Proceedings of the National Academy of Science of the United States of America 96, 1999, pp.8573–8.
A.N. Vgontzas, R.S. Legro, A.Bixler, A. Grayerv, A. Kales and G.P. Chrousos, ‘Polycystic ovarian syndrome is associated with obstructive sleep aponea and daytime sleepiness: Role of insulin resistance.’ Journal of Clinical Endocrinology and Metabolism 86, 2001, pp.517–520.
C. Wolfrrum, E. Aslimaz, E. Luca, J.M. Friedman, M. Stoffel, ‘Foxa2 regulated lipid metabolism and ketogenesis in the liver during fasting and in diabetes Nature 432, 2004, pp.1027-1032.
B.O.Yildiz, H.Yarali, H.Oguz and M.Bayraktar,‘Glucose intolerance, insulin resistance, and hyperandrogenemia in first degree relatives of women with polycystic ovary syndrome.’ Journal of Clinical Endocrinology and Metabolism 88, 2003, pp.2031–2036.
'The Impact of maternal thyroid disease on the developing fetus: implications for diagnosis, treatment and screening' Thyroid 2005 Atlanta, Georgia January 12-13, 15, 2004 , pp.25-79.